Momentum in medical and tech-focused small caps continues to explode, led by

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), which surged to another new 52-week high today, up a staggering +563% in the past 3 months. Originally covered on June 12, 2025 when stock closed at $0.63 the prior trading day, see entire news article. With short interest rapidly collapsing, the biotech innovator has become a market game-changer—drawing massive investor attention across institutional and retail circles alike. Analysts say there are no signs of slowing down as ImmunoPrecise’s platform continues to deliver on its immuno-oncology potential.

Meanwhile, Health In Tech Inc. (NASDAQ: HIT), a rising Insurtech platform powered by third-party AI, confirmed it will report Q2 2025 financial results on Monday, July 21, after market close, followed by a live earnings call. With shares up +86% over the past month—from $0.59 to $1.10—traders are weighing bullish into the announcement. HIT’s AI-based quote-to-card system is rapidly modernizing health plan delivery and underwriting across the insurance space, with momentum continuing to build on Wall Street.

Synergy CHC Corp. (NASDAQ: SNYR) also remains on breakout watch, rallying on news of a landmark expansion with McKesson Corp. (NYSE: MCK). The partnership enables SNYR’s flagship FOCUSfactor® supplement and Focus + Energy™ beverage lines to penetrate thousands of pharmacies across North America. SNYR’s retail footprint already includes, Costco (NASDAQ: COST), Walmart (NYSE: WMT), Amazon (NASDAQ: AMZN), CVS (NYSE: CVS) Walgreens (NASDAQ: WBA) and McKesson Corporation (NYSE: MCK) with the brand targeting over 50,000 distribution points by year-end.

In the resource sector, Power Metallic Mines Inc. (TSXV: PNPN | OTCQB: PNPNF) is leveraging advanced mining tech and AI to accelerate exploration across its newly expanded Quebec assets, including the Lion, Tiger, and Nisk zones. Following a major acquisition with Li-FT Power Exploration and over 20,000 meters of drilling underway, PNPN is financially strong, carbon-neutral, and expanding into Saudi Arabia—positioning itself as a global battery metals contender.

On the clinical front, Kairos Pharma Ltd. (NYSE American: KAPA) posted positive Phase 2 safety data from its lead drug candidate, ENV-105 (carotuximab), in patients with metastatic castration-resistant prostate cancer. The CD105 antagonist was well tolerated when combined with apalutamide, showing no Grade 3 or 4 toxicities and demonstrating strong early safety signals—a promising step toward advancing next-generation immunotherapy treatments in oncology.

Elsewhere in biotech, Polyrizon Ltd. (NASDAQ: PLRZ) received a continued listing notification from the Nasdaq Hearings Panel, securing its presence on the Nasdaq Capital Market. Polyrizon’s unique C&C™ hydrogel technology—a nasal spray forming a barrier against viruses and allergens—offers compelling long-term potential in infection prevention and allergy management. The platform is described as a “biological mask” and has drawn interest for its novel approach to nasal cavity protection.

Rounding out the sector momentum is Sunrun Inc. (NASDAQ: RUN), which announced it will release Q2 2025 earnings on Wednesday, August 6, after market close. The solar energy leader remains a key player in renewable energy infrastructure and consumer-focused clean energy systems.

Investor Radar:

• ImmunoPrecise (NASDAQ: IPA) – Biotech Surge Leader, +563%
• Health In Tech (NASDAQ: HIT) – AI Insurtech, +86% Ahead of Earnings
• Synergy CHC (NASDAQ: SNYR) – FOCUSfactor® Expansion w/ $MCK
• Power Metallic (TSXV: PNPN | OTCQB: PNPNF) – Mining Acquisition & Exploration Boom
• Kairos Pharma (NYSE American: KAPA) – Positive Phase 2 Cancer Trial Data
• Polyrizon (NASDAQ: PLRZ) – Novel Intranasal Barrier Tech, Listing Secured
• Sunrun (NASDAQ: RUN) – Solar Leader Earnings Incoming

As earnings season ramps up and small-cap innovation stories gain traction, investors are watching these breakout names closely. From medical breakthroughs to green energy to AI-powered platforms, the market is signaling a renewed appetite for growth—and these companies are delivering.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com